470
Views
80
CrossRef citations to date
0
Altmetric
Research Article

Elastic liposomes as carriers for oral delivery and the brain distribution of (+)-catechin

, , , , &
Pages 709-718 | Received 05 Oct 2010, Accepted 27 Dec 2010, Published online: 08 Feb 2011

References

  • Ban JY, Jeon SY, Bae K, Song KS, Seong YH. (2006). Catechin and epicatechin from Smilacis chinae rhizome protect cultured rat cortical neurons against amyloid beta protein (25-35)-induced neurotoxicity through inhibition of cytosolic calcium elevation. Life Sci, 79, 2251–2259.
  • Béduneau A, Hindré F, Clavreul A, Leroux JC, Saulnier P, Benoit JP. (2008). Brain targeting using novel lipid nanovectors. J Control Release, 126, 44–49.
  • Blache D, Durand P, Prost M, Loreau N. (2002). (+)-Catechin inhibits platelet hyperactivity induced by an acute iron load in vivo. Free Radic Biol Med, 33, 1670–1680.
  • Bodor N, Buchwald P. (2002). Barriers to remember: brain-targeting chemical delivery systems and Alzheimer’s disease. Drug Discov Today, 7, 766–774.
  • Cai Y, Anavy ND, Chow HH. (2002). Contribution of presystemic hepatic extraction to the low oral bioavailability of green tea catechins in rats. Drug Metab Dispos, 30, 1246–1249.
  • Catterall F, King LJ, Clifford MN, Ioannides C. (2003). Bioavailability of dietary doses of 3H-labelled tea antioxidants (+)-catechin and (–)-epicatechin in rat. Xenobiotica, 33, 743–753.
  • Cevc G, Blume G. (1992). Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta, 1104, 226–232.
  • Dreosti IE. (2000). Antioxidant polyphenols in tea, cocoa, and wine. Nutrition, 16, 692–694.
  • El Maghraby GM, Williams AC, Barry BW. (2000a). Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. Int J Pharm, 196, 63–74.
  • El Maghraby GM, Williams AC, Barry BW. (2000b). Skin delivery of oestradiol from lipid vesicles: importance of liposome structure. Int J Pharm, 204, 159–169.
  • El Maghraby GM, Williams AC, Barry BW. (2004). Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes. Int J Pharm, 276, 143–161.
  • Fang JY, Hung CF, Hwang TL, Huang YL. (2005). Physicochemical characteristics and in vivo deposition of liposome-encapsulated tea catechins by topical and intratumor administrations. J Drug Target, 13, 19–27.
  • Fang JY, Hwang TL, Huang YL, Fang CL. (2006a). Enhancement of the transdermal delivery of catechins by liposomes incorporating anionic surfactants and ethanol. Int J Pharm, 310, 131–138.
  • Fang JY, Hwang TL, Huang YL. (2006b). Liposomes as vehicles for enhancing drug delivery via skin routes. Curr Nanosci, 2, 55–70.
  • Fang JY, Lee WR, Shen SC, Huang YL. (2006c). Effect of liposome encapsulation of tea catechins on their accumulation in basal cell carcinomas. J Dermatol Sci, 42, 101–109.
  • Fang YP, Tsai YH, Wu PC, Huang YB. (2008). Comparison of 5-aminolevulinic acid-encapsulated liposome versus ethosome for skin delivery for photodynamic therapy. Int J Pharm, 356, 144–152.
  • Ge Z, Zhang XX, Gan L, Gan Y. (2008). Redispersible, dry emulsion of lovastatin protects against intestinal metabolism and improves bioavailability. Acta Pharmacol Sin, 29, 990–997.
  • Godin B, Touitou E. (2005). Erythromycin ethosomal systems: physicochemical characterization and enhanced antibacterial activity. Curr Drug Deliv, 2, 269–275.
  • Godin B, Touitou E. (2004). Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier. J Control Release, 94, 365–379.
  • Heo HJ, Lee CY. (2005). Epicatechin and catechin in cocoa inhibit amyloid beta protein induced apoptosis. J Agric Food Chem, 53, 1445–1448.
  • Hiremath PS, Soppimath KS, Betageri GV. (2009). Proliposomes of exemestane for improved oral delivery: formulation and in vitro evaluation using PAMPA, Caco-2 and rat intestine. Int J Pharm, 380, 96–104.
  • Honeywell-Nguyen PL, Frederik PM, Bomans PH, Junginger HE, Bouwstra JA. (2002). Transdermal delivery of pergolide from surfactant-based elastic and rigid vesicles: characterization and in vitro transport studies. Pharm Res, 19, 991–997.
  • Honeywell-Nguyen PL, Wouter Groenink HW, de Graaff AM, Bouwstra JA. (2003). The in vivo transport of elastic vesicles into human skin: effects of occlusion, volume and duration of application. J Control Release, 90, 243–255.
  • Kaur IP, Bhandari R, Bhandari S, Kakkar V. (2008). Potential of solid lipid nanoparticles in brain targeting. J Control Release, 127, 97–109.
  • Kelsey JE, Langelier NA, Oriel BS, Reedy C. (2009). The effects of systemic, intrastriatal, and intrapallidal injections of caffeine and systemic injections of A2A and A1 antagonists on forepaw stepping in the unilateral 6-OHDA-lesioned rat. Psychopharmacology (Berl), 201, 529–539.
  • Lee CM, Lee HC, Lee KY. (2005). O-palmitoylcurdlan sulfate (OPCurS)-coated liposomes for oral drug delivery. J Biosci Bioeng, 100, 255–259.
  • Li H, Song JH, Park JS, Han K. (2003). Polyethylene glycol-coated liposomes for oral delivery of recombinant human epidermal growth factor. Int J Pharm, 258, 11–19.
  • Ling SS, Magosso E, Khan NA, Yuen KH, Barker SA. (2006). Enhanced oral bioavailability and intestinal lymphatic transport of a hydrophilic drug using liposomes. Drug Dev Ind Pharm, 32, 335–345.
  • Luo Y, Chen D, Ren L, Zhao X, Qin J. (2006). Solid lipid nanoparticles for enhancing vinpocetine’s oral bioavailability. J Control Release, 114, 53–59.
  • Mandel S, Youdim MB. (2004). Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases. Free Radic Biol Med, 37, 304–317.
  • Nakagawa K, Miyazawa T. (1997). Absorption and distribution of tea catechin, (–)-epigallocatechin-3-gallate, in the rat. J Nutr Sci Vitaminol, 43, 679–684.
  • Ogue S, Takahashi Y, Onishi H, Machida Y. (2006). Preparation of double liposomes and their efficiency as an oral vaccine carrier. Biol Pharm Bull, 29, 1223–1228.
  • Paliwal R, Rai S, Vaidya B, Khatri K, Goyal AK, Mishra N, Mehta A, Vyas SP. (2009). Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery. Nanomedicine, 5, 184–191.
  • Patel RP, Patel MM. (2007). Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30. Pharm Dev Technol, 12, 21–33.
  • Porat Y, Abramowitz A, Gazit E. (2006). Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. Chem Biol Drug Des, 67, 27–37.
  • Kumar R, Gupta RB, Betageri GV. (2001). Formulation, characterization, and in vitro release of glyburide from proliposomal beads. Drug Deliv, 8, 25–27.
  • Reimold I, Domke D, Bender J, Seyfried CA, Radunz HE, Fricker G. (2008). Delivery of nanoparticles to the brain detected by fluorescence microscopy. Eur J Pharm Biopharm, 70, 627–632.
  • Soni V, Kohli DV, Jain SK. (2005). Transferrin coupled liposomes as drug delivery carriers for brain targeting of 5-florouracil. J Drug Target, 13, 245–250.
  • Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. (2000). Ethosomes- novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release, 65, 403–418.
  • Unno K, Takabayashi F, Kishido T, Oku N. (2004). Suppressive effect of green tea catechins on morphologic and functional regression of the brain in aged mice with accelerated senescence (SAMP10). Exp Gerontol, 39, 1027–1034.
  • Unno K, Yamamoto H, Maeda K, Takabayashi F, Yoshida H, Kikunaga N, Takamori N, Asahina S, Iguchi K, Sayama K, Hoshino M. (2009). Protection of brain and pancreas from high-fat diet: effects of catechin and caffeine. Physiol Behav, 96, 262–269.
  • Venkatesan N, Uchino K, Amagase K, Ito Y, Shibata N, Takada K. (2006). Gastro-intestinal patch system for the delivery of erythropoietin. J Control Release, 111, 19–26.
  • Wilson B, Samanta MK, Santhi K, Kumar KP, Paramakrishnan N, Suresh B. (2008). Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer’s disease. Brain Res, 1200, 159–168.
  • Wu WB, Chiang HS, Fang JY, Chen SK, Huang CC, Hung CF. (2006). (+)-Catechin prevents ultraviolet B-induced human keratinocyte death via inhibition of JNK phosphorylation. Life Sci, 79, 801–807.
  • Xie Y, Ye L, Zhang X, Cui W, Lou J, Nagai T, Hou X. (2005). Transport of nerve growth factor encapsulated into liposomes across the blood-brain barrier: in vitro and in vivo studies. J Control Release, 105, 106–119.
  • Zaveri NT. (2006). Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications. Life Sci, 78, 2073–2080.
  • Zhang H, Yao M, Morrison RA, Chong S. (2003). Commonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats. Arch Pharm Res, 26, 768–772.
  • Zhang N, Ping QN, Huang GH, Xu WF. (2005). Investigation of lectin-modified insulin liposomes as carriers for oral administration. Int J Pharm, 294, 247–259.
  • Zhu QY, Holt RR, Lazarus SA, Ensunsa JL, Hammerstone JF, Schmitz HH, Keen CL. (2002). Stability of the flavan-3-ols epicatechin and catechin and related dimeric procyanidins derived from cocoa. J Agric Food Chem, 50, 1700–1705.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.